The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Morris, Christine Joanna
    Consultant born in April 1972
    Individual (4 offsprings)
    Officer
    2015-01-23 ~ now
    OF - director → CIF 0
    Mrs Christine Joanna Morris
    Born in April 1972
    Individual (4 offsprings)
    Person with significant control
    2016-04-06 ~ now
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
    PE - Ownership of voting rights - 75% or more as a member of a firmCIF 0
    PE - Right to appoint or remove directorsCIF 0
    PE - Has significant influence or control as a member of a firmCIF 0
  • 2
    Morris, Jason
    Company Director born in August 1969
    Individual (4 offsprings)
    Officer
    2015-01-23 ~ now
    OF - director → CIF 0
parent relation
Company in focus

KEYSTONE PHARMA CONSULTING LIMITED

Standard Industrial Classification
62020 - Information Technology Consultancy Activities
Brief company account
Fixed Assets
20,496 GBP2024-03-31
32,493 GBP2023-03-31
Current Assets
113,641 GBP2024-03-31
105,223 GBP2023-03-31
Creditors
Amounts falling due within one year
-40,222 GBP2024-03-31
-32,202 GBP2023-03-31
Net Current Assets/Liabilities
73,419 GBP2024-03-31
73,021 GBP2023-03-31
Total Assets Less Current Liabilities
93,915 GBP2024-03-31
105,514 GBP2023-03-31
Accrued Liabilities/Deferred Income
-1,388 GBP2024-03-31
-764 GBP2023-03-31
Net Assets/Liabilities
92,527 GBP2024-03-31
104,750 GBP2023-03-31
Equity
92,527 GBP2024-03-31
104,750 GBP2023-03-31
Average Number of Employees
42023-04-01 ~ 2024-03-31
32022-04-01 ~ 2023-03-31

  • KEYSTONE PHARMA CONSULTING LIMITED
    Info
    Registered number 09403717
    18 Yaverland Drive, Bagshot, Surrey GU19 5DX
    Private Limited Company incorporated on 2015-01-23 (10 years 4 months). The company status is Active.
    The last date of confirmation statement was made at 2025-01-23
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.